Recombinant fowlpox virus vaccines against Australian virulent Marek's disease virus. Gene sequence analysis and comparison of vaccine efficacy in specific pathogen free and production chickens

Virus Research

Volumn 50, Issue 1, 1997, Pages 23-33

  Heine, Hans G ^a   Foord, Adam J ^a   Young, Peter L ^b   Hooper, Peter T ^a   Lehrbach, Philip R ^c   Boyle, David B ^a  

^a CSIRO   (Australia)

^b DEPARTMENT OF AGRICULTURE AND FISHERIES   (Australia)

^c Cyanamid Websters Pty Ltd   (Australia)

Author keywords

Avian herpesvirus; Glycoproteins; Live vaccine; Marek's disease virus; Recombinant fowlpox virus

Indexed keywords

LIVE VACCINE; VIRUS GLYCOPROTEIN; VIRUS VACCINE;

ANIMAL EXPERIMENT; ARTICLE; AVIAN LYMPHOMATOSIS HERPETOVIRUS; CHICKEN; CONTROLLED STUDY; DRUG EFFICACY; FOWLPOX VIRUS; GENE SEQUENCE; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTION; VIRUS RECOMBINANT;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, VIRAL; CHICKENS; CLONING, MOLECULAR; FOWLPOX VIRUS; HERPESVIRUS 2, GALLID; MAREK DISEASE; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, DNA; SPECIFIC PATHOGEN-FREE ORGANISMS; VACCINES, SYNTHETIC; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES; VIRULENCE;

ANIMALIA; AVES; FOWLPOX VIRUS; GALLID HERPESVIRUS 2; GALLUS GALLUS; HERPESVIRIDAE; HERPETOVIRUS; MELEAGRID HERPESVIRUS 1;

EID: 0030795575     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(97)00049-X     Document Type: Article

References (29)

1. Bacon L.D., Witter R.L. Influence of B-haplotype on the relative efficacy of Marek's disease vaccines of different serotypes. Avian Dis. 37:1993;53-59.
2. Binns M.M., Ross N.L.J. Nucleotide sequence of the Marek's disease virus (MDV) RB-1B A antigen gene and the identification of the MDV A antigen as the herpes simplex virus-1 glycoprotein C homologue. Virus Res. 12:1989;371-382.
3. Boyle D.B., Coupar B.E.H., Gibbs A.J., Seigman L.J., Both G.W. Fowlpox virus thymidine kinase: nucleotide sequence and relationships to other thymidine kinases. Virology. 156:1987;355-365.
4. Boyle D.B., Heine H.G. Recombinant fowpox virus vaccines for poultry. Immunol. Cell Biol. 71:1993;391-397.
5. Boyle D.B., Heine H.G. Influence of dose and route of inoculation on responses of chickens to recombinant fowlpox virus vaccines. Vet. Microbiol. 41:1994;173-181.
6. Briles W.E., Stone H.A., Cole R.K. Marek's disease: effects of B histocompatibility alloalleles in resistant and susceptible chicken lines. Science. 195:1977;193-195.
7. Brunovskis P., Velicer L.F. The Marek's disease virus (MDV) unique short region: Alphaherpesvirus-homologous, fowlpox virus-homologous, and MDV-specific genes. Virology. 206:1995;324-338.
8. Buckmaster A.E., Scott S.D., Sanderson M.J., Boursnell M.E.G., Ross N.L.J., Binns M.W. Gene sequence and mapping data from Marek's disease virus and herpesvirus of turkeys: Implications for herpesvirus classification. J. Gen. Virol. 69:1988;2033-2042.
9. Ghiasi H., Kaiwar R., Nesburn A.B., Slanina S., Wechsler S.L. Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH, and gI): Comparative protection against lethal challenge in mice. J. Virol. 68:1994;2118-2126.
10. Ghiasi H., Nesburn A.B., Wechsler S.L. Vaccination with a cocktail of seven recombinantly expressed HSV-1 glycoproteins protects against ocular HSV-1 challenge more efficiently than vaccination with any individual glycoprotein. Vaccine. 14:1996;107-112.
11. Heine H.-G., Boyle D.B. Infectious bursal disease virus structural protein VP2 expressed by a fowlpox virus recombinant confers protection against disease in chickens. Arch. Virol. 131:1993;277-292.
12. Ihara T., Kato A., Ueda S., Ishihama A., Hirai K. Comparison of the sequence of the glycoprotein A (gA) gene between Md5 and BC-1 strains of Marek's disease. Virus Genes. 3:1989;127-140.
13. Inglis S.C. Challenges and progress in developing herpesvirus vaccines. Tibtech. 13:1995;135-142.
14. Isfort R.J., Qian Z., Jones D., Silva R.F., Witter R., Kung H.-J. Integration of multiple chicken retroviruses into multiple chicken herpesviruses: Herpesviral gD as a common target of integration. Virology. 203:1994;125-133.
15. Jang H.-K., Kitazawa T., Ono M., Kawaguchi Y., Maeda K., Yokoyama N., Tohya Y., Niikura M., Mikami T. Protection studies against Marek's disease using baculovirus-expressed glycoproteins B and C of Marek's disease virus type 1. Avian Pathol. 25:1996;5-24.
16. Kaufman, J., Wallny, H.J., 1996. Chicken MHC molecules, disease resistance and the evolutionary origin of birds. In: Vainio, O., Imhof, B.A. (Eds.), Current Topics in Microbiology and Immunology, Vol. 212. Immunology and Developmental Biology of the Chicken. Springer, Berlin.
17. McKimm-Breschkin J.L., Faragher J.T., Withell J., Forsyth W.M. Isolation of very virulent Marek's disease viruses from vaccinated chickens in Australia. Aust. Vet. J 67:1990;205-209.
18. Nazerian K., Lee L.F., Yanagida N., Ogawa R. Protection against Marek's disease by a fowlpox virus recombinant expressing the glycoprotein B of Marek's disease virus. J. Virol. 66:1992;1409-1413.
19. Nazerian K., Witter R.L., Lee L.F., Yanagida N. Protection and synergism by recombinant fowl pox vaccines expressing genes from Marek's disease virus. Avian Dis. 40:1996;368-376.
20. Riviere M., Tartaglia J., Perkus M.E., Norton E.K., Bongermino C.M., Lacoste F., Duret C., Desmettre P., Paoletti E. Protection of mice and swine from pseudorabies virus conferred by vaccinia virus-based recombinants. J. Virol. 66:1992;3424-3434.
21. Roizman, B., 1996. Herpesviridae. In: Fields, B.N., Knipe, D.M., Howley P.M. et al. (Eds.), Fields Virology, 3rd edn., ch. 71, Lippincott-Raven, Philadelphia, pp. 2221-2230.
22. Roizman, B., Sears, A.E., 1996. Herpes simplex viruses and their replication. In: Fields, B.N., Knipe, D.M., Howley P.M. et al. (Eds.), Fields Virology, 3rd edn., ch. 72, Lippincott-Raven, Philadelphia, pp. 2231-2295.
23. Ross L.J.N., Sanderson M., Scott S.D., Binns M.M., Doel T., Milne B. Nucleotide sequence and characterization of the Marek's disease virus homologue of glycoprotein B of herpes simplex virus. J. Gen. Virol. 70:1989;1789-1804.
24. Ross L.J.N., Binns M.M., Pastorek J. DNA sequence and organization of genes in a 5.5 kbp EcoRI fragment mapping in the short unique segment of Marek's disease virus (strain RB-1B). J. Gen. Virol. 72:1991;949-954.
25. Ross N., O'Sullivan G., Coudert F. Influence of chicken genotype on protection against Marek's disease by a herpesvirus of turkeys recombinant expressing the glycoprotein B (gB) of Marek's disease virus. Vaccine. 14:1996;187-189.
26. Silva R.F., Lee L.F. Monoclonal antibody-mediated immunoprecipitation of proteins from cells infected with Marek's disease virus of turkey herpesvirus. Virology. 136:1984;307-320.
27. Taylor J., Christensen L., Gettig R., Goebel J., Bouquet J.F., Mickle T.R., Paoletti E. Efficacy of a recombinant folpox-based Newcastle disease virus vaccine candidate against velogenic and respiratory challenge. Avian Dis. 40:1996;173-180.
28. Yanagida N., Ogawa R., Lee L.F., Nazerian K. Recombinant fowlpox viruses expressing the glycoprotein B homolog and the pp38 gene of Marek's disease virus. J. Virol. 66:1992;1402-1408.
29. Zerbes M., Tannock G.A., Jenner R.J., Young P.L. Some characteristics of a recent virulent isolate of Marek's disease virus. Aust. Vet. J 71:1994;21-22.